Skip to content
SHL Telemedicine
  • Home
  • About
    • SHL at a Glance
    • Mission
    • Client Portfolio
    • Partners
    • Leadership Team
  • Solutions & Products
    • Professionals
      • Solutions For CHF
      • Solution for COPD
      • Readmissions Solutions
      • Products
    • Consumers
      • Cardiac Monitoring Service
      • Personal Health Record
    • Telemedicine 24/7
  • Investors
    • Share Information
      • Share Price
      • Shareholder Structure
    • Newsroom
    • SEC Filings / Submissions
    • Annual Reports
      • Annual Reports
      • Key Figures
    • General Meeting
    • Corporate Governance
    • Event Calendar
    • IR Contact
  • Newsroom
  • Contact
  • Toggle website search
Press Escape to close the search panel.
  • Home
  • About
    • SHL at a Glance
    • Mission
    • Client Portfolio
    • Partners
    • Leadership Team
  • Solutions & Products
    • Professionals
      • Solutions For CHF
      • Solution for COPD
      • Readmissions Solutions
      • Products
    • Consumers
      • Cardiac Monitoring Service
      • Personal Health Record
    • Telemedicine 24/7
  • Investors
    • Share Information
      • Share Price
      • Shareholder Structure
    • Newsroom
    • SEC Filings / Submissions
    • Annual Reports
      • Annual Reports
      • Key Figures
    • General Meeting
    • Corporate Governance
    • Event Calendar
    • IR Contact
  • Newsroom
  • Contact
  • Toggle website search
Search this website

SHL Telemedicine to Commence Trading on NASDAQ Under the Symbol “SHLT”

For more information, click here

Continue ReadingSHL Telemedicine to Commence Trading on NASDAQ Under the Symbol “SHLT”
  • Post published:March 31, 2023
  • Post category:

SHL Telemedicine announces additional cash proceeds of CHF 8.4 million

for more information, click here

Continue ReadingSHL Telemedicine announces additional cash proceeds of CHF 8.4 million
  • Post published:February 20, 2023
  • Post category:

SHL Telemedicine announces cash proceeds of CHF 12.6 million

for more information, click here

Continue ReadingSHL Telemedicine announces cash proceeds of CHF 12.6 million
  • Post published:January 23, 2023
  • Post category:

SHL Telemedicine announces Confidential Submission of Draft Registration Statement for Proposed NASDAQ Listing

For more information, click here

Continue ReadingSHL Telemedicine announces Confidential Submission of Draft Registration Statement for Proposed NASDAQ Listing
  • Post published:December 29, 2022
  • Post category:

SHL announces invitation to an Annual General Meeting

For more information, click here

Continue ReadingSHL announces invitation to an Annual General Meeting
  • Post published:November 17, 2022
  • Post category:

SHL announces half-year results 2022 – continued progress on all strategic fronts

For more information, click here

Continue ReadingSHL announces half-year results 2022 – continued progress on all strategic fronts
  • Post published:September 22, 2022
  • Post category:

SHL Telemedicine German operation awarded a large seven year Doctors‘ Virtual Visit and Telehealth Service contract by BARMER

For more information, click here

Continue ReadingSHL Telemedicine German operation awarded a large seven year Doctors‘ Virtual Visit and Telehealth Service contract by BARMER
  • Post published:September 8, 2022
  • Post category:

SHL publicizes disclosure of shareholdings – dissolution of the Alroy family shareholders group

For more information, click here

Continue ReadingSHL publicizes disclosure of shareholdings – dissolution of the Alroy family shareholders group
  • Post published:August 18, 2022
  • Post category:

SHL announces invitation to a Special General Meeting

For more information, please click here

Continue ReadingSHL announces invitation to a Special General Meeting
  • Post published:July 4, 2022
  • Post category:
  • Go to the previous page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Go to the next page

SHL HEADQUARTERS

  • Yigal Alon 90
    Tel Aviv, Israel 67891
  • +972-3-5612212

EUROPE

  • Balanstraße 69 b
    Munich, Germany, 81541
  • +49-89-48059-0

USA

  • 350 Motor Parkway, Suite 204
    Hauppauge, NY 11788
  • +1-877-777-9794

Subscribe for News and Updates


Loading

Accessibility Toolbar

  • Powered with favoriteLove by Codenroll